Signablok, Inc.

12 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Sep 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Jul 7 to 21, 2027 · next Jul 7

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,538,558	Inhibition of TCR signaling with peptide variants In force Term ends Sep 30, 2030 · From the USPTO record	In force	Term ends Sep 30, 2030	From the USPTO record
US 10,525,152	Methods and Compositions for Targeted Imaging In force Ends no later than Oct 10, 2030 · Medium confidence	In force	Ends no later than Oct 10, 2030	Medium confidence
US 10,894,098	Methods And Compositions For Targeted Imaging In force Term ends Oct 10, 2030 · High confidence	In force	Term ends Oct 10, 2030	High confidence
US 8,513,185	Inhibition of TREM receptor signaling with peptide variants In force Term ends Oct 13, 2030 · From the USPTO record	In force	Term ends Oct 13, 2030	From the USPTO record
US 9,981,004	Inhibition of TREM receptor signaling with peptide variants In force Term ends Oct 13, 2030 · From the USPTO record	In force	Term ends Oct 13, 2030	From the USPTO record
US 11,638,739	Inhibition of Trem Receptor Signaling with Peptide Variants In force Ends no later than Oct 13, 2030 · Low confidence	In force	Ends no later than Oct 13, 2030	Low confidence
US 12,168,034	Inhibition of TREM receptor signaling with peptide variants In force Term ends Oct 13, 2030 · From the USPTO record	In force	Term ends Oct 13, 2030	From the USPTO record
US 12,779,061	METHODS FOR TARGETED IMAGING WITH SPHERICAL rHDLs In force Term ends Aug 28, 2031 · High confidence	In force	Term ends Aug 28, 2031	High confidence
US 12,036,294	Spherical rHDLs For Targeted Imaging In force Term ends Nov 24, 2031 · High confidence	In force	Term ends Nov 24, 2031	High confidence
US 11,097,020	Methods and Compositions for Targeted Delivery In force Ends no later than Jul 27, 2032 · Low confidence	In force	Ends no later than Jul 27, 2032	Low confidence

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 no status recorded

List them